Churchill Capital Corp X Files S-4 for $1.8B De-SPAC Merger with ColdQuanta, Inc. and $126.5M PIPE at Deep Discount
Summary
Churchill Capital Corp X filed an S-4 for its de-SPAC merger with ColdQuanta, Inc. (to be renamed Infleqtion, Inc.), valuing the target at $1.8 billion and including a $126.5 million PIPE at a significant discount to the current market price, indicating substantial dilution for existing public shareholders.
Key Events
-
Business Combination Agreement
Churchill Capital Corp X (SPAC) will merge with ColdQuanta, Inc. (d/b/a Infleqtion), a global leader in neutral atom-based quantum technology. The combined entity will be renamed Infleqtion, Inc.
-
Target Valuation
ColdQuanta, Inc. is valued at an aggregate equity value of $1.8 billion. Consideration will be paid entirely in shares of the post-merger company's common stock, priced at $10.00 per share.
-
PIPE Financing Details
A Private Investment in Public Equity (PIPE) of $126.5 million will be raised through the issuance of 12,654,760 shares of common stock at a purchase price of $10.00 per share. This is a significant discount to the current stock price of $18.63.
-
Shareholder Dilution
Existing public shareholders face substantial dilution. In a no-redemption scenario, their ownership will be 19.3%, falling to 0% in a maximum redemption scenario. The PIPE pricing at $10.00 per share, compared to the current market price, further exacerbates dilution for non-redeeming public shareholders.
Analysis
The S-4 filing outlines the definitive merger agreement for Churchill Capital Corp X to combine with ColdQuanta, Inc., a quantum technology company. While this transaction allows the SPAC to fulfill its mandate and provides ColdQuanta with public market access and capital, the terms introduce substantial dilution and risk for existing public shareholders. The $126.5 million PIPE investment is priced at $10.00 per share, a significant discount to the current market price of $18.63, which will dilute existing shareholders. ColdQuanta operates in an early-stage, capital-intensive quantum technology sector with a history of operating losses, adding a high degree of risk to the combined entity's future prospects. Investors should carefully consider the significant dilution and the inherent risks of the target's business model.
At the time of this filing, CCCX was trading at $18.63 on NASDAQ in the Technology sector, with a market capitalization of approximately $968.7M. The 52-week trading range was $10.03 to $27.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.